These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18681777)

  • 21. Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis.
    Potter C; Hyrich KL; Tracey A; Lunt M; Plant D; Symmons DP; Thomson W; Worthington J; Emery P; Morgan AW; Wilson AG; Isaacs J; Barton A;
    Ann Rheum Dis; 2009 Jan; 68(1):69-74. PubMed ID: 18375541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble TNF receptor treatment does not affect raised TGF beta levels in RA.
    Cuchacovich R; Espinoza LR
    Ann Rheum Dis; 2002 Jul; 61(7):667; author reply 667. PubMed ID: 12079925
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
    Tijhuis GJ; van de Putte LB; Breedveld FC
    Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1880-5. PubMed ID: 11605312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etanercept (Enbrel): update on therapeutic use.
    Spencer-Green G
    Ann Rheum Dis; 2000 Nov; 59 Suppl 1(Suppl 1):i46-9. PubMed ID: 11053088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling and cost-effectiveness analysis of etanercept in adults with rheumatoid arthritis in Japan: a preliminary analysis.
    Tanno M; Nakamura I; Ito K; Tanaka H; Ohta H; Kobayashi M; Tachihara A; Nagashima M; Yoshino S; Nakajima A
    Mod Rheumatol; 2006; 16(2):77-84. PubMed ID: 16633926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New drugs and treatment strategies for rheumatoid arthritis].
    Fantini F
    Recenti Prog Med; 2003 Sep; 94(9):361-79. PubMed ID: 12942798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The soluble tumor necrosis factor receptor etanercept: a new strategy for the treatment of autoimmune rheumatic disease.
    Cole P; Rabasseda X
    Drugs Today (Barc); 2004 Apr; 40(4):281-324. PubMed ID: 15190385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TNF-alpha inhibitors offer hope to RA patients.
    Wimett L
    Nurse Pract; 2003 Oct; 28(10):40-8. PubMed ID: 14560130
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of rheumatoid arthritis by TNF-blocking agents.
    Graninger W; Smolen J
    Int Arch Allergy Immunol; 2002 Jan; 127(1):10-4. PubMed ID: 11893849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of rheumatoid arthritis and autoimmune hepatitis in a patient treated with the tumor necrosis factor inhibitor, etanercept.
    Umekita K; Miyauchi S; Ueno S; Takajo I; Kusumoto K; Hasuike S; Umekita Y; Tanaka H; Nagata K; Nagatomo Y; Kataoka H; Shimoda K; Okayama A
    Intern Med; 2011; 50(11):1245-9. PubMed ID: 21628943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Etanercept: long-term clinical experience in rheumatoid arthritis and other arthritis.
    Cobo-Ibáñez T; Martín-Mola E
    Expert Opin Pharmacother; 2007 Jun; 8(9):1373-97. PubMed ID: 17563271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. -174G/C interleukin-6 gene promoter polymorphism predicts therapeutic response to etanercept in rheumatoid arthritis.
    Jančić I; Arsenović-Ranin N; Sefik-Bukilica M; Zivojinović S; Damjanov N; Spasovski V; Srzentić S; Stanković B; Pavlović S
    Rheumatol Int; 2013 Jun; 33(6):1481-6. PubMed ID: 23233117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term etanercept therapy favors weight gain and ameliorates cachexia in rheumatoid arthritis patients: roles of gut hormones and leptin.
    Chen CY; Tsai CY; Lee PC; Lee SD
    Curr Pharm Des; 2013; 19(10):1956-64. PubMed ID: 23305268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Etanercept increases adiponectin level in woman with rheumatoid arthritis.
    Lewicki M; Kotyla P; Kucharz E
    Clin Rheumatol; 2008 Oct; 27(10):1337-8. PubMed ID: 18651101
    [No Abstract]   [Full Text] [Related]  

  • 35. Etanercept treatment of rheumatoid arthritis in the "real world".
    Smith MD
    Ann Rheum Dis; 2003 Jan; 62(1):95-6; author reply 96. PubMed ID: 12480688
    [No Abstract]   [Full Text] [Related]  

  • 36. Etanercept improves rheumatoid arthritis partially responsive to methotrexate.
    Cutolo M
    Clin Exp Rheumatol; 2001; 19(6):626-7. PubMed ID: 11791631
    [No Abstract]   [Full Text] [Related]  

  • 37. Differentiating the efficacy of tumor necrosis factor inhibitors.
    Haraoui B
    J Rheumatol Suppl; 2005 Mar; 74():3-7. PubMed ID: 15742457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Etanercept in rheumatoid arthritis.
    Alldred A
    Expert Opin Pharmacother; 2001 Jul; 2(7):1137-48. PubMed ID: 11583065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Etanercept].
    Kameda H
    Nihon Rinsho; 2013 Jul; 71(7):1214-7. PubMed ID: 23961669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical experience with soluble TNF p75 receptor in rheumatoid arthritis.
    Franklin CM
    Semin Arthritis Rheum; 1999 Dec; 29(3):172-81. PubMed ID: 10622681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.